Form 4 for NRXS Neuraxis, INC
Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-23 · accession 0001811824-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-12-29 | 2025-12-23 | NRXS | Aharon Gil | Dir | P - Purchase | $3.52 | +286.1K | 286.1K | New | +$1.01M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-12-23 | P | A | 286,138 | $3.52 | 286,138 | I By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P. | — | — | (F1) Rosalind Master Fund L.P. purchased 286,138 common shares at $3.52 (F2) Each Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein. |